Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types
(NASDAQ: ADAG) Delayed: 3.84 -0.1 (2.54%)
Previous Close $3.94    52 Week High $ 
Open $3.97    52 Week Low $ 
Day High $4.00    P/E N/A 
Day Low $3.77    EPS $ 
Volume 252,043       

(NASDAQ: ADAG) Delayed: 3.84 -0.1 (2.54%)
Previous Close $3.94    52 Week High $ 
Open $3.97    52 Week Low $ 
Day High $4.00    P/E N/A 
Day Low $3.77    EPS $ 
Volume 252,043